|
|
|
|
| LEADER |
01845nam a22003735i 4500 |
| 001 |
978-3-319-65720-2 |
| 005 |
20191029021053.0 |
| 007 |
cr nn 008mamaa |
| 008 |
171122s2017 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319657202
|
| 024 |
7 |
|
|a 10.1007/978-3-319-65720-2
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a In Vivo Reprogramming in Regenerative Medicine
|c edited by Açelya Yilmazer.
|
| 250 |
|
|
|a 1st ed. 2017.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Humana,
|c 2017.
|
| 300 |
|
|
|a XVII, 103 p. 15 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Stem Cell Biology and Regenerative Medicine,
|
| 505 |
0 |
|
|a Chapter 1. Introduction to in vivo cell Reprogramming Technology -- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells -- Chapter 3. Direct Reprogramming to Beta Cells -- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration -- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency -- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration -- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.
|
| 650 |
|
0 |
|a Regenerative medicine.
|
| 650 |
|
0 |
|a Tissue engineering.
|
| 650 |
|
0 |
|a Stem cells.
|
| 650 |
|
0 |
|a Cell culture.
|
| 650 |
|
0 |
|a Surgical transplantation.
|
| 650 |
1 |
4 |
|a Regenerative Medicine/Tissue Engineering.
|
| 650 |
2 |
4 |
|a Stem Cells.
|
| 650 |
2 |
4 |
|a Cell Culture.
|
| 650 |
2 |
4 |
|a Transplant Surgery.
|
| 700 |
1 |
|
|a Yilmazer, Açelya.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-65720-2
|